Indivior Pharmaceuticals (INDV) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $32.45, -3.48% vs the prior close of $33.62.
- Volume 4.21M shares, 1.9x its 50-day average (heavy).
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
INDV slides 3.5% to $32.45, a 3-month low on 1.9x normal volume. Closed at $32.45, -3.48% vs the prior close of $33.62. Day range $32.31–$33.76, opened at $33.47.
INDV daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — INDV slides 3.5% to $32.45, a 3-month low on 1.9x normal volume
- Closed at $32.45, -3.48% vs the prior close of $33.62. Day range $32.31–$33.76, opened at $33.47.
- Volume was 4.21M shares, 1.9x its 50-day average of 2.19M — unusually heavy trading.
- Price is -9.8% vs its 50-day average ($35.98) and -9.1% vs its 200-day average ($35.69).
- 52-week range $23.72–$42.81; today's close sits at 46% of that range, 24.2% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — INDV dips 1.6% to $33.62, a 3-month low, 3 down days in a row
- Closed at $33.62, -1.58% vs the prior close of $34.16. Day range $33.54–$34.85, opened at $34.57.
- Volume was 1.75M shares, 0.8x its 50-day average of 2.24M.
- Price is -6.9% vs its 50-day average ($36.10) and -5.8% vs its 200-day average ($35.71).
- 52-week range $23.72–$42.81; today's close sits at 52% of that range, 21.5% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 14, 2026 — INDV slides 3.6% to $34.16, a 3-month low
- Closed at $34.16, -3.56% vs the prior close of $35.42. Day range $33.99–$36.30, opened at $35.11.
- Volume was 2.78M shares, 1.2x its 50-day average of 2.33M.
- Price is -5.6% vs its 50-day average ($36.20) and -4.4% vs its 200-day average ($35.72).
- 52-week range $23.67–$42.81; today's close sits at 55% of that range, 20.2% below the 52-week high.
Oct 13, 2026 — INDV dips 1.8% to $35.42
- Closed at $35.42, -1.77% vs the prior close of $36.06. Day range $35.19–$36.26, opened at $36.09.
- Volume was 1.93M shares, 0.8x its 50-day average of 2.42M.
- Price is -2.3% vs its 50-day average ($36.25) and -0.9% vs its 200-day average ($35.73).
- 52-week range $23.55–$42.81; today's close sits at 62% of that range, 17.3% below the 52-week high.
Oct 12, 2026 — INDV rises 0.6% to $36.06 on 3.3x normal volume
- Closed at $36.06, +0.64% vs the prior close of $35.83. Day range $35.37–$36.32, opened at $36.00.
- Volume was 7.47M shares, 3.3x its 50-day average of 2.30M — unusually heavy trading.
- Price is -0.6% vs its 50-day average ($36.29) and +0.9% vs its 200-day average ($35.73).
- 52-week range $22.95–$42.81; today's close sits at 66% of that range, 15.8% below the 52-week high.
Oct 9, 2026 — INDV rises 1.1% to $35.83 on 2.1x normal volume
- Closed at $35.83, +1.07% vs the prior close of $35.45. Day range $35.21–$36.14, opened at $35.45.
- Volume was 4.80M shares, 2.1x its 50-day average of 2.23M — unusually heavy trading.
- Price is -1.5% vs its 50-day average ($36.37) and +0.3% vs its 200-day average ($35.74).
- 52-week range $22.95–$42.81; today's close sits at 65% of that range, 16.3% below the 52-week high.
Oct 8, 2026 — INDV dips 1.9% to $35.45
- Closed at $35.45, -1.88% vs the prior close of $36.13. Day range $34.85–$36.35, opened at $35.72.
- Volume was 1.53M shares, 0.7x its 50-day average of 2.23M.
- Price is -2.8% vs its 50-day average ($36.46) and -0.8% vs its 200-day average ($35.74).
- 52-week range $22.95–$42.81; today's close sits at 63% of that range, 17.2% below the 52-week high.
Oct 7, 2026 — INDV rises 0.6% to $36.13
- Closed at $36.13, +0.64% vs the prior close of $35.90. Day range $35.58–$36.29, opened at $35.58.
- Volume was 1.77M shares, 0.8x its 50-day average of 2.23M.
- Price is -1.1% vs its 50-day average ($36.55) and +1.1% vs its 200-day average ($35.74).
- 52-week range $22.78–$42.81; today's close sits at 67% of that range, 15.6% below the 52-week high.
Oct 6, 2026 — INDV ends flat (-0.3%) to $35.90
- Closed at $35.90, -0.25% vs the prior close of $35.99. Day range $35.03–$36.15, opened at $35.96.
- Volume was 2.39M shares, 1.1x its 50-day average of 2.21M.
- Price is -2.0% vs its 50-day average ($36.65) and +0.5% vs its 200-day average ($35.74).
- 52-week range $22.56–$42.81; today's close sits at 66% of that range, 16.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — INDV rises 0.8% to $35.99
- Closed at $35.99, +0.78% vs the prior close of $35.71. Day range $35.73–$36.26, opened at $36.00.
- Volume was 3.00M shares, 1.4x its 50-day average of 2.16M.
- Price is -2.0% vs its 50-day average ($36.73) and +0.7% vs its 200-day average ($35.74).
- 52-week range $22.56–$42.81; today's close sits at 66% of that range, 15.9% below the 52-week high.
Oct 2, 2026 — INDV rises 0.9% to $35.71
- Closed at $35.71, +0.93% vs the prior close of $35.38. Day range $35.26–$36.15, opened at $35.46.
- Volume was 1.67M shares, 0.8x its 50-day average of 2.18M.
- Price is -3.0% vs its 50-day average ($36.82) and -0.1% vs its 200-day average ($35.73).
- 52-week range $22.56–$42.81; today's close sits at 65% of that range, 16.6% below the 52-week high.
INDV latest news & SEC filings
Every SEC filing by or about INDV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 30, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
Sep 11, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 11, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Anderson Woodrow D bought 1,500 shares at $35.69 (≈$53.53K) on Aug 27, 2026
- Anderson Woodrow D bought 1,500 shares at $35.69 (≈$53.53K) on Aug 27, 2026
- Anderson Woodrow D bought 1,500 shares at $35.69 (≈$53.53K) on Aug 27, 2026
- Anderson Woodrow D bought 1,500 shares at $35.69 (≈$53.53K) on Aug 27, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Anderson Woodrow D bought 1,500 shares at $36.28 (≈$54.42K) on Aug 5, 2026
- Anderson Woodrow D bought 1,500 shares at $36.28 (≈$54.42K) on Aug 5, 2026
- Anderson Woodrow D bought 1,500 shares at $36.28 (≈$54.42K) on Aug 5, 2026
- Anderson Woodrow D bought 1,500 shares at $36.28 (≈$54.42K) on Aug 5, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade INDV
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 26, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.45% (largest 3.6%).
- Liquidity: about 2.40M shares (≈$77.76M) trade per day on average.
- 52-week position: $32.45 vs a range of $23.72–$42.81 (46% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 13 open-market buys, 12 sales; latest: Woodrow D Anderson bought 1,500 shares on Aug 27, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 6, 2026; 8-K Sep 17, 2026.
- Share count: 118.01M shares outstanding (Jul 28, 2026), -5.4% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
INDV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 33.47 | 33.76 | 32.31 | 32.45 | 4.21M |
| Oct 15, 2026 | 34.57 | 34.85 | 33.54 | 33.62 | 1.75M |
| Oct 14, 2026 | 35.11 | 36.30 | 33.99 | 34.16 | 2.78M |
| Oct 13, 2026 | 36.09 | 36.26 | 35.19 | 35.42 | 1.93M |
| Oct 12, 2026 | 36.00 | 36.32 | 35.37 | 36.06 | 7.47M |
| Oct 9, 2026 | 35.45 | 36.14 | 35.21 | 35.83 | 4.80M |
| Oct 8, 2026 | 35.72 | 36.35 | 34.85 | 35.45 | 1.53M |
| Oct 7, 2026 | 35.58 | 36.29 | 35.58 | 36.13 | 1.77M |
| Oct 6, 2026 | 35.96 | 36.15 | 35.03 | 35.90 | 2.39M |
| Oct 5, 2026 | 36.00 | 36.26 | 35.73 | 35.99 | 3.00M |
| Oct 2, 2026 | 35.46 | 36.15 | 35.26 | 35.71 | 1.67M |
| Oct 1, 2026 | 35.85 | 36.21 | 35.25 | 35.38 | 1.88M |
| Sep 30, 2026 | 36.54 | 36.60 | 35.79 | 35.85 | 1.67M |
| Sep 29, 2026 | 36.74 | 37.05 | 36.08 | 36.59 | 2.01M |
| Sep 28, 2026 | 35.50 | 36.96 | 35.43 | 36.88 | 1.17M |
| Sep 25, 2026 | 35.90 | 36.22 | 35.72 | 35.82 | 1.10M |
| Sep 24, 2026 | 35.71 | 36.28 | 35.57 | 36.00 | 2.22M |
| Sep 23, 2026 | 36.23 | 36.90 | 35.78 | 35.91 | 1.06M |
| Sep 22, 2026 | 35.53 | 36.63 | 35.48 | 36.19 | 2.22M |
| Sep 21, 2026 | 35.00 | 35.63 | 34.77 | 35.53 | 1.30M |
About Indivior Pharmaceuticals
Indivior Pharmaceuticals (INDV) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NORTH CHESTERFIELD, VA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1625297.
INDV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Joseph Ciaffoni | Chief Executive Officer | Jun 23, 2026 |
| Keith Humphreys | Director | May 14, 2026 |
| Stuart A Kingsley | Director | May 14, 2026 |
| Daniel A Ninivaggi | Director | May 14, 2026 |
| Barbara Ryan | Director | May 14, 2026 |
| Mark Stejbach | Director | May 14, 2026 |
| Juliet Thompson | Director | May 14, 2026 |
| David E. Wheadon | Director | May 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Woodrow D Anderson | Chief Accounting Officer | Aug 27, 2026 |
| Patrick A Barry | Chief Commercial Officer | Feb 12, 2026 |
| Jeffrey W Burris | Chief Legal Officer | Mar 5, 2026 |
| Joseph Ciaffoni | Chief Executive Officer | Jun 23, 2026 |
| Christian Heidbreder | Chief Scientific Officer | Jul 13, 2026 |
| Ryan Preblick | Chief Financial Officer | Jun 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 27, 2026 | Woodrow D Anderson | Buy | 1,500 | $35.69 |
| Aug 27, 2026 | Woodrow D Anderson | Buy | 1,500 | $35.69 |
| Aug 27, 2026 | Woodrow D Anderson | Buy | 1,500 | $35.69 |
| Aug 27, 2026 | Woodrow D Anderson | Buy | 1,500 | $35.69 |
| Aug 5, 2026 | Woodrow D Anderson | Buy | 1,500 | $36.28 |
| Aug 5, 2026 | Woodrow D Anderson | Buy | 1,500 | $36.28 |
| Aug 5, 2026 | Woodrow D Anderson | Buy | 1,500 | $36.28 |
| Aug 5, 2026 | Woodrow D Anderson | Buy | 1,500 | $36.28 |
| Jul 10, 2026 | Christian Heidbreder | Sale | 18,586 | $41.14 |
| Jul 10, 2026 | Christian Heidbreder | Sale | 18,586 | $41.14 |
| Jul 10, 2026 | Christian Heidbreder | Sale | 18,586 | $41.14 |
| Jul 10, 2026 | Christian Heidbreder | Sale | 18,586 | $41.14 |
| Jun 11, 2026 | Christian Heidbreder | Sale | 18,586 | $38.06 |
| Jun 11, 2026 | Christian Heidbreder | Sale | 18,586 | $38.06 |
| Jun 11, 2026 | Christian Heidbreder | Sale | 18,586 | $38.06 |
INDV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.24B | $210.00M | 1.64 | $-27.00M |
| Dec 31, 2024 | $1.19B | $7.00M | 0.05 | $36.00M |
| Dec 31, 2023 | $1.09B | $-126.00M | -0.92 | $-300.00M |
| Dec 31, 2022 | $901.00M | $-44.00M | -0.32 | $-4.00M |
Latest balance sheet: total assets $1.23B, total liabilities $1.44B, cash $222.00M (as of Jun 30, 2026).
INDV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $37.37 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $36.78 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $33.71 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $29.13 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $20.20 |
| Apr 24, 2025 | 8-K Item 2.02 (results) | $10.76 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on INDV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.